In this study, we report the synthesis of silver nanoparticles (AgNP’s) by reducing silver ions from a solution of silver nitrate with an aqueous extract from Azadirachta indica. Using silver ions as the catalyst, nanoparticles were formed in 8[Formula: see text]min without the use of toxic chemicals. As evidenced by UV-vis spectroscopy, a broad surface plasmon resonance spectrum at 225[Formula: see text]nm was detected, which indicates the colloidal solution of silver nanoparticles is stable and produces silver nanoparticles. As revealed by the fourier transform-infrared spectrometer (FTIR) analysis, the flower extract contained a variety of biomolecules that acted as capping and reducing agents for the synthesis of AgNPs. As determined by X-ray diffraction (XRD), silver nanoparticles displayed a crystalline structure and ranged in size from 18 to 39[Formula: see text]nm. In addition to these findings, transmission electron microscopy (TEM) images showed that the silver nanoparticles were spherical and rod-shaped, as confirmed by scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDAX). A variety of pathogenic bacteria, such as Klebsiella pneumoniae, Escherichia coli, Bacillus subtilis and Staphylococcus aureus, were tested against AgNP’s antibacterial properties. A significant inhibition zone was observed for Escherichia coli when AgNPs were applied at different concentrations. Silver nanoparticles were shown to have antidiabetic effects through a diphtheria assay with inhibition rates ranging from 31.09% to 83.33% for concentrations of 50–250[Formula: see text][Formula: see text]g/mL. As researchers seek natural sources of compounds with potential health benefits, silver nanoparticles were also investigated for their antioxidant properties.
No takes yet. Share an insight, caveat, or question.
Renuka et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: